[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Cancer Monoclonal Antibodies Sales Market Report 2017

December 2017 | 114 pages | ID: G17058CD4B1EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Cancer Monoclonal Antibodies market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Cancer Monoclonal Antibodies for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Cancer Monoclonal Antibodies market competition by top manufacturers/players, with Cancer Monoclonal Antibodies sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • F. Hoffmann-La Roche
  • Amgen
  • Bristol-Myers Squibb
  • Takeda Pharmaceuticals
  • Pfizer
  • Merck
  • Eli Lilly
  • Sanofi
  • Janssen Biotech
  • Novartis
  • AbbVie
  • Boehringer Ingelheim
  • AstraZeneca
  • Bayer
  • Biogen
  • TG Therapeutics
  • CTI BioPharma
  • Intas Pharmaceuticals
  • Kyowa Hakko Kirin
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Naked mAbs
  • Conjugated mAbs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospitals
  • Retail Pharmacies
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Cancer Monoclonal Antibodies Sales Market Report 2017

1 CANCER MONOCLONAL ANTIBODIES MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Monoclonal Antibodies
1.2 Classification of Cancer Monoclonal Antibodies by Product Category
  1.2.1 Global Cancer Monoclonal Antibodies Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Cancer Monoclonal Antibodies Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Naked mAbs
  1.2.4 Conjugated mAbs
1.3 Global Cancer Monoclonal Antibodies Market by Application/End Users
  1.3.1 Global Cancer Monoclonal Antibodies Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Retail Pharmacies
1.4 Global Cancer Monoclonal Antibodies Market by Region
  1.4.1 Global Cancer Monoclonal Antibodies Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Cancer Monoclonal Antibodies Status and Prospect (2012-2022)
  1.4.3 China Cancer Monoclonal Antibodies Status and Prospect (2012-2022)
  1.4.4 Europe Cancer Monoclonal Antibodies Status and Prospect (2012-2022)
  1.4.5 Japan Cancer Monoclonal Antibodies Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Cancer Monoclonal Antibodies Status and Prospect (2012-2022)
  1.4.7 India Cancer Monoclonal Antibodies Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Cancer Monoclonal Antibodies (2012-2022)
  1.5.1 Global Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2022)
  1.5.2 Global Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2022)

2 GLOBAL CANCER MONOCLONAL ANTIBODIES COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Cancer Monoclonal Antibodies Market Competition by Players/Suppliers
  2.1.1 Global Cancer Monoclonal Antibodies Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Cancer Monoclonal Antibodies Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Cancer Monoclonal Antibodies (Volume and Value) by Type
  2.2.1 Global Cancer Monoclonal Antibodies Sales and Market Share by Type (2012-2017)
  2.2.2 Global Cancer Monoclonal Antibodies Revenue and Market Share by Type (2012-2017)
2.3 Global Cancer Monoclonal Antibodies (Volume and Value) by Region
  2.3.1 Global Cancer Monoclonal Antibodies Sales and Market Share by Region (2012-2017)
  2.3.2 Global Cancer Monoclonal Antibodies Revenue and Market Share by Region (2012-2017)
2.4 Global Cancer Monoclonal Antibodies (Volume) by Application

3 UNITED STATES CANCER MONOCLONAL ANTIBODIES (VOLUME, VALUE AND SALES PRICE)

3.1 United States Cancer Monoclonal Antibodies Sales and Value (2012-2017)
  3.1.1 United States Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
  3.1.2 United States Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
  3.1.3 United States Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
3.2 United States Cancer Monoclonal Antibodies Sales Volume and Market Share by Players
3.3 United States Cancer Monoclonal Antibodies Sales Volume and Market Share by Type
3.4 United States Cancer Monoclonal Antibodies Sales Volume and Market Share by Application

4 CHINA CANCER MONOCLONAL ANTIBODIES (VOLUME, VALUE AND SALES PRICE)

4.1 China Cancer Monoclonal Antibodies Sales and Value (2012-2017)
  4.1.1 China Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
  4.1.2 China Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
  4.1.3 China Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
4.2 China Cancer Monoclonal Antibodies Sales Volume and Market Share by Players
4.3 China Cancer Monoclonal Antibodies Sales Volume and Market Share by Type
4.4 China Cancer Monoclonal Antibodies Sales Volume and Market Share by Application

5 EUROPE CANCER MONOCLONAL ANTIBODIES (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Cancer Monoclonal Antibodies Sales and Value (2012-2017)
  5.1.1 Europe Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
  5.1.2 Europe Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
5.2 Europe Cancer Monoclonal Antibodies Sales Volume and Market Share by Players
5.3 Europe Cancer Monoclonal Antibodies Sales Volume and Market Share by Type
5.4 Europe Cancer Monoclonal Antibodies Sales Volume and Market Share by Application

6 JAPAN CANCER MONOCLONAL ANTIBODIES (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Cancer Monoclonal Antibodies Sales and Value (2012-2017)
  6.1.1 Japan Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
  6.1.2 Japan Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
6.2 Japan Cancer Monoclonal Antibodies Sales Volume and Market Share by Players
6.3 Japan Cancer Monoclonal Antibodies Sales Volume and Market Share by Type
6.4 Japan Cancer Monoclonal Antibodies Sales Volume and Market Share by Application

7 SOUTHEAST ASIA CANCER MONOCLONAL ANTIBODIES (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Cancer Monoclonal Antibodies Sales and Value (2012-2017)
  7.1.1 Southeast Asia Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
7.2 Southeast Asia Cancer Monoclonal Antibodies Sales Volume and Market Share by Players
7.3 Southeast Asia Cancer Monoclonal Antibodies Sales Volume and Market Share by Type
7.4 Southeast Asia Cancer Monoclonal Antibodies Sales Volume and Market Share by Application

8 INDIA CANCER MONOCLONAL ANTIBODIES (VOLUME, VALUE AND SALES PRICE)

8.1 India Cancer Monoclonal Antibodies Sales and Value (2012-2017)
  8.1.1 India Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2017)
  8.1.2 India Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2017)
  8.1.3 India Cancer Monoclonal Antibodies Sales Price Trend (2012-2017)
8.2 India Cancer Monoclonal Antibodies Sales Volume and Market Share by Players
8.3 India Cancer Monoclonal Antibodies Sales Volume and Market Share by Type
8.4 India Cancer Monoclonal Antibodies Sales Volume and Market Share by Application

9 GLOBAL CANCER MONOCLONAL ANTIBODIES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 F. Hoffmann-La Roche
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Amgen
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Amgen Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Bristol-Myers Squibb
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Takeda Pharmaceuticals
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Pfizer
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Pfizer Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Merck
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Merck Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Eli Lilly
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Eli Lilly Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Sanofi
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Sanofi Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Janssen Biotech
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Janssen Biotech Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Novartis
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Cancer Monoclonal Antibodies Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Novartis Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 AbbVie
9.12 Boehringer Ingelheim
9.13 AstraZeneca
9.14 Bayer
9.15 Biogen
9.16 TG Therapeutics
9.17 CTI BioPharma
9.18 Intas Pharmaceuticals
9.19 Kyowa Hakko Kirin

10 CANCER MONOCLONAL ANTIBODIES MAUFACTURING COST ANALYSIS

10.1 Cancer Monoclonal Antibodies Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Cancer Monoclonal Antibodies
10.3 Manufacturing Process Analysis of Cancer Monoclonal Antibodies

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Cancer Monoclonal Antibodies Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Cancer Monoclonal Antibodies Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET FORECAST (2017-2022)

14.1 Global Cancer Monoclonal Antibodies Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Cancer Monoclonal Antibodies Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Cancer Monoclonal Antibodies Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Cancer Monoclonal Antibodies Price and Trend Forecast (2017-2022)
14.2 Global Cancer Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Cancer Monoclonal Antibodies Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Cancer Monoclonal Antibodies Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Cancer Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Cancer Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Cancer Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Cancer Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Cancer Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Cancer Monoclonal Antibodies Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Cancer Monoclonal Antibodies Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Cancer Monoclonal Antibodies Sales Forecast by Type (2017-2022)
  14.3.2 Global Cancer Monoclonal Antibodies Revenue Forecast by Type (2017-2022)
  14.3.3 Global Cancer Monoclonal Antibodies Price Forecast by Type (2017-2022)
14.4 Global Cancer Monoclonal Antibodies Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Cancer Monoclonal Antibodies
Figure Global Cancer Monoclonal Antibodies Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Cancer Monoclonal Antibodies Sales Volume Market Share by Type (Product Category) in 2016
Figure Naked mAbs Product Picture
Figure Conjugated mAbs Product Picture
Figure Global Cancer Monoclonal Antibodies Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Cancer Monoclonal Antibodies by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Global Cancer Monoclonal Antibodies Market Size (Million USD) by Regions (2012-2022)
Figure United States Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Cancer Monoclonal Antibodies Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Cancer Monoclonal Antibodies Sales Volume (K Units) (2012-2017)
Table Global Cancer Monoclonal Antibodies Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Cancer Monoclonal Antibodies Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Cancer Monoclonal Antibodies Sales Share by Players/Suppliers
Figure 2017 Cancer Monoclonal Antibodies Sales Share by Players/Suppliers
Figure Global Cancer Monoclonal Antibodies Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Cancer Monoclonal Antibodies Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Cancer Monoclonal Antibodies Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Cancer Monoclonal Antibodies Revenue Share by Players
Table 2017 Global Cancer Monoclonal Antibodies Revenue Share by Players
Table Global Cancer Monoclonal Antibodies Sales (K Units) and Market Share by Type (2012-2017)
Table Global Cancer Monoclonal Antibodies Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Cancer Monoclonal Antibodies by Type (2012-2017)
Figure Global Cancer Monoclonal Antibodies Sales Growth Rate by Type (2012-2017)
Table Global Cancer Monoclonal Antibodies Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Cancer Monoclonal Antibodies Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Monoclonal Antibodies by Type (2012-2017)
Figure Global Cancer Monoclonal Antibodies Revenue Growth Rate by Type (2012-2017)
Table Global Cancer Monoclonal Antibodies Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Cancer Monoclonal Antibodies Sales Share by Region (2012-2017)
Figure Sales Market Share of Cancer Monoclonal Antibodies by Region (2012-2017)
Figure Global Cancer Monoclonal Antibodies Sales Growth Rate by Region in 2016
Table Global Cancer Monoclonal Antibodies Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Cancer Monoclonal Antibodies Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Cancer Monoclonal Antibodies by Region (2012-2017)
Figure Global Cancer Monoclonal Antibodies Revenue Growth Rate by Region in 2016
Table Global Cancer Monoclonal Antibodies Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Cancer Monoclonal Antibodies Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Cancer Monoclonal Antibodies by Region (2012-2017)
Figure Global Cancer Monoclonal Antibodies Revenue Market Share by Region in 2016
Table Global Cancer Monoclonal Antibodies Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Cancer Monoclonal Antibodies Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Cancer Monoclonal Antibodies by Application (2012-2017)
Figure Global Cancer Monoclonal Antibodies Sales Market Share by Application (2012-2017)
Figure United States Cancer Monoclonal Antibodies Sales (K Units) and Growth Rate (2012-2017)
Figure United States Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Cancer Monoclonal Antibodies Sales Price (USD/Unit) Trend (2012-2017)
Table United States Cancer Monoclonal Antibodies Sales Volume (K Units) by Players (2012-2017)
Table United States Cancer Monoclonal Antibodies Sales Volume Market Share by Players (2012-2017)
Figure United States Cancer Monoclonal Antibodies Sales Volume Market Share by Players in 2016
Table United States Cancer Monoclonal Antibodies Sales Volume (K Units) by Type (2012-2017)
Table United States Cancer Monoclonal Antibodies Sales Volume Market Share by Type (2012-2017)
Figure United States Cancer Monoclonal Antibodies Sales Volume Market Share by Type in 2016
Table United States Cancer Monoclonal Antibodies Sales Volume (K Units) by Application (2012-2017)
Table United States Cancer Monoclonal Antibodies Sales Volume Market Share by Application (2012-2017)
Figure United States Cancer Monoclonal Antibodies Sales Volume Market Share by Application in 2016
Figure China Cancer Monoclonal Antibodies Sales (K Units) and Growth Rate (2012-2017)
Figure China Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Cancer Monoclonal Antibodies Sales Price (USD/Unit) Trend (2012-2017)
Table China Cancer Monoclonal Antibodies Sales Volume (K Units) by Players (2012-2017)
Table China Cancer Monoclonal Antibodies Sales Volume Market Share by Players (2012-2017)
Figure China Cancer Monoclonal Antibodies Sales Volume Market Share by Players in 2016
Table China Cancer Monoclonal Antibodies Sales Volume (K Units) by Type (2012-2017)
Table China Cancer Monoclonal Antibodies Sales Volume Market Share by Type (2012-2017)
Figure China Cancer Monoclonal Antibodies Sales Volume Market Share by Type in 2016
Table China Cancer Monoclonal Antibodies Sales Volume (K Units) by Application (2012-2017)
Table China Cancer Monoclonal Antibodies Sales Volume Market Share by Application (2012-2017)
Figure China Cancer Monoclonal Antibodies Sales Volume Market Share by Application in 2016
Figure Europe Cancer Monoclonal Antibodies Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Cancer Monoclonal Antibodies Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Cancer Monoclonal Antibodies Sales Volume (K Units) by Players (2012-2017)
Table Europe Cancer Monoclonal Antibodies Sales Volume Market Share by Players (2012-2017)
Figure Europe Cancer Monoclonal Antibodies Sales Volume Market Share by Players in 2016
Table Europe Cancer Monoclonal Antibodies Sales Volume (K Units) by Type (2012-2017)
Table Europe Cancer Monoclonal Antibodies Sales Volume Market Share by Type (2012-2017)
Figure Europe Cancer Monoclonal Antibodies Sales Volume Market Share by Type in 2016
Table Europe Cancer Monoclonal Antibodies Sales Volume (K Units) by Application (2012-2017)
Table Europe Cancer Monoclonal Antibodies Sales Volume Market Share by Application (2012-2017)
Figure Europe Cancer Monoclonal Antibodies Sales Volume Market Share by Application in 2016
Figure Japan Cancer Monoclonal Antibodies Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Cancer Monoclonal Antibodies Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Cancer Monoclonal Antibodies Sales Volume (K Units) by Players (2012-2017)
Table Japan Cancer Monoclonal Antibodies Sales Volume Market Share by Players (2012-2017)
Figure Japan Cancer Monoclonal Antibodies Sales Volume Market Share by Players in 2016
Table Japan Cancer Monoclonal Antibodies Sales Volume (K Units) by Type (2012-2017)
Table Japan Cancer Monoclonal Antibodies Sales Volume Market Share by Type (2012-2017)
Figure Japan Cancer Monoclonal Antibodies Sales Volume Market Share by Type in 2016
Table Japan Cancer Monoclonal Antibodies Sales Volume (K Units) by Application (2012-2017)
Table Japan Cancer Monoclonal Antibodies Sales Volume Market Share by Application (2012-2017)
Figure Japan Cancer Monoclonal Antibodies Sales Volume Market Share by Application in 2016
Figure Southeast Asia Cancer Monoclonal Antibodies Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Cancer Monoclonal Antibodies Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Cancer Monoclonal Antibodies Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Cancer Monoclonal Antibodies Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Cancer Monoclonal Antibodies Sales Volume Market Share by Players in 2016
Table Southeast Asia Cancer Monoclonal Antibodies Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Cancer Monoclonal Antibodies Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Cancer Monoclonal Antibodies Sales Volume Market Share by Type in 2016
Table Southeast Asia Cancer Monoclonal Antibodies Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Cancer Monoclonal Antibodies Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Cancer Monoclonal Antibodies Sales Volume Market Share by Application in 2016
Figure India Cancer Monoclonal Antibodies Sales (K Units) and Growth Rate (2012-2017)
Figure India Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Cancer Monoclonal Antibodies Sales Price (USD/Unit) Trend (2012-2017)
Table India Cancer Monoclonal Antibodies Sales Volume (K Units) by Players (2012-2017)
Table India Cancer Monoclonal Antibodies Sales Volume Market Share by Players (2012-2017)
Figure India Cancer Monoclonal Antibodies Sales Volume Market Share by Players in 2016
Table India Cancer Monoclonal Antibodies Sales Volume (K Units) by Type (2012-2017)
Table India Cancer Monoclonal Antibodies Sales Volume Market Share by Type (2012-2017)
Figure India Cancer Monoclonal Antibodies Sales Volume Market Share by Type in 2016
Table India Cancer Monoclonal Antibodies Sales Volume (K Units) by Application (2012-2017)
Table India Cancer Monoclonal Antibodies Sales Volume Market Share by Application (2012-2017)
Figure India Cancer Monoclonal Antibodies Sales Volume Market Share by Application in 2016
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales Global Market Share (2012-2017
Figure F. Hoffmann-La Roche Cancer Monoclonal Antibodies Revenue Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Cancer Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Cancer Monoclonal Antibodies Sales Growth Rate (2012-2017)
Figure Amgen Cancer Monoclonal Antibodies Sales Global Market Share (2012-2017
Figure Amgen Cancer Monoclonal Antibodies Revenue Global Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales Global Market Share (2012-2017
Figure Bristol-Myers Squibb Cancer Monoclonal Antibodies Revenue Global Market Share (2012-2017)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales Growth Rate (2012-2017)
Figure Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales Global Market Share (2012-2017
Figure Takeda Pharmaceuticals Cancer Monoclonal Antibodies Revenue Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Cancer Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Cancer Monoclonal Antibodies Sales Growth Rate (2012-2017)
Figure Pfizer Cancer Monoclonal Antibodies Sales Global Market Share (2012-2017
Figure Pfizer Cancer Monoclonal Antibodies Revenue Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Cancer Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Cancer Monoclonal Antibodies Sales Growth Rate (2012-2017)
Figure Merck Cancer Monoclonal Antibodies Sales Global Market Share (2012-2017
Figure Merck Cancer Monoclonal Antibodies Revenue Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Cancer Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Cancer Monoclonal Antibodies Sales Growth Rate (2012-2017)
Figure Eli Lilly Cancer Monoclonal Antibodies Sales Global Market Share (2012-2017
Figure Eli Lilly Cancer Monoclonal Antibodies Revenue Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Cancer Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Cancer Monoclonal Antibodies Sales Growth Rate (2012-2017)
Figure Sanofi Cancer Monoclonal Antibodies Sales Global Market Share (2012-2017
Figure Sanofi Cancer Monoclonal Antibodies Revenue Global Market Share (2012-2017)
Table Janssen Biotech Basic Information List
Table Janssen Biotech Cancer Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Janssen Biotech Cancer Monoclonal Antibodies Sales Growth Rate (2012-2017)
Figure Janssen Biotech Cancer Monoclonal Antibodies Sales Global Market Share (2012-2017
Figure Janssen Biotech Cancer Monoclonal Antibodies Revenue Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Cancer Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Cancer Monoclonal Antibodies Sales Growth Rate (2012-2017)
Figure Novartis Cancer Monoclonal Antibodies Sales Global Market Share (2012-2017
Figure Novartis Cancer Monoclonal Antibodies Revenue Global Market Share (2012-2017)
Table AbbVie Basic Information List
Table Boehringer Ingelheim Basic Information List
Table AstraZeneca Basic Information List
Table Bayer Basic Information List
Table Biogen Basic Information List
Table TG Therapeutics Basic Information List
Table CTI BioPharma Basic Information List
Table Intas Pharmaceuticals Basic Information List
Table Kyowa Hakko Kirin Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Monoclonal Antibodies
Figure Manufacturing Process Analysis of Cancer Monoclonal Antibodies
Figure Cancer Monoclonal Antibodies Industrial Chain Analysis
Table Raw Materials Sources of Cancer Monoclonal Antibodies Major Players in 2016
Table Major Buyers of Cancer Monoclonal Antibodies
Table Distributors/Traders List
Figure Global Cancer Monoclonal Antibodies Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Cancer Monoclonal Antibodies Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Cancer Monoclonal Antibodies Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Cancer Monoclonal Antibodies Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Cancer Monoclonal Antibodies Sales Volume Market Share Forecast by Regions in 2022
Table Global Cancer Monoclonal Antibodies Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Cancer Monoclonal Antibodies Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Cancer Monoclonal Antibodies Revenue Market Share Forecast by Regions in 2022
Figure United States Cancer Monoclonal Antibodies Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Cancer Monoclonal Antibodies Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Cancer Monoclonal Antibodies Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Cancer Monoclonal Antibodies Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Cancer Monoclonal Antibodies Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Cancer Monoclonal Antibodies Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Cancer Monoclonal Antibodies Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Cancer Monoclonal Antibodies Sales (K Units) Forecast by Type (2017-2022)
Figure Global Cancer Monoclonal Antibodies Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Cancer Monoclonal Antibodies Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Cancer Monoclonal Antibodies Revenue Market Share Forecast by Type (2017-2022)
Table Global Cancer Monoclonal Antibodies Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Cancer Monoclonal Antibodies Sales (K Units) Forecast by Application (2017-2022)
Figure Global Cancer Monoclonal Antibodies Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories